Grifols (GIFLF) Cash & Equivalents (QoQ) (2010 - 2020)

Grifols (GIFLF) Cash & Equivalents (QoQ) (2010 - 2020) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 96,436,181.12 Bn 96,436,176.16 Bn 7.76 Bn
2 Eli Lilly 1,017.30 Bn 1,012.01 Bn 16.22 Bn
3 Johnson & Johnson 579.61 Bn 557.55 Bn 15.96 Bn
4 AbbVie 402.30 Bn 392.96 Bn 10.78 Bn
5 Merck 294.24 Bn 288.59 Bn 12.09 Bn
6 Amgen 191.82 Bn 179.78 Bn 5.87 Bn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn
8 Pfizer 149.05 Bn 136.28 Bn -1.21 Bn
9 Bristol Myers Squibb 116.33 Bn 105.88 Bn 8.07 Bn
10 Grifols - - -

Historic Data

Download Data
DateValue
Dec 31, 2020 -42.73%
Mar 31, 2020 -111.38%
Dec 31, 2019 29.82%
Mar 31, 2019 -145.92%
Dec 31, 2018 74.31%
Sep 30, 2018 -15.15%
Jun 30, 2018 3,624.94%
Mar 31, 2018 -97.95%
Jun 30, 2017 426.36%
Mar 31, 2017 -83.78%
Dec 31, 2016 -3.85%
Sep 30, 2016 10.23%
Jun 30, 2016 -17.96%
Mar 31, 2016 -11.25%
Dec 31, 2015 26.24%
Sep 30, 2015 13.80%
Jun 30, 2015 -3.29%
Mar 31, 2015 -33.17%
Dec 31, 2013 49.11%
Sep 30, 2013 3.41%